Metraipolis › archive › dc_347d2f83e71a
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study — Europe PMC PMID:40286311
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40286311
- DOI
- 10.1093/rheumatology/keaf232
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:47:24.757Z
- SHA-256 of the archived text
7817ad8e4c3b856eaf9c53c9d92acb18540dc06635a76241c0fc74a863f8b148- Stable URL of this page
https://metraipolis.com/documento/dc_347d2f83e71a
How to cite
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study — Europe PMC PMID:40286311 — Europe PMC (en), https://europepmc.org/article/MED/40286311 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_347d2f83e71a (Metraipolis archive dc_347d2f83e71a, sha256 7817ad8e4c3b856eaf9c53c9d92acb18540dc06635a76241c0fc74a863f8b148)
BibTeX
@misc{dc347d2f83e71a,
title = {Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study — Europe PMC PMID:40286311},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40286311},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_347d2f83e71a; sha256 7817ad8e4c3b856eaf9c53c9d92acb18540dc06635a76241c0fc74a863f8b148},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40286311. Agents can read the archived copy with the MCP tool read_document.